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Background: Studies on the association of birth by caesarean section (C/S) and allergies have produced conflicting
findings. Furthermore, evidence on whether this association may differ in those at risk of atopy is limited. This study
aims to investigate the association of mode of delivery with asthma and atopic sensitization and the extent to
which any effect is modified by family history of allergies.
Methods: Asthma outcomes were assessed cross-sectionally in 2216 children at age 8 on the basis of parents’
responses to the ISAAC questionnaire whilst skin prick tests to eleven aeroallergens were also performed in a
subgroup of 746 children. Adjusted odds ratios of asthma and atopy by mode of delivery were estimated in
multivariable logistic models while evidence of effect modification was examined by introducing interaction terms
in the models.
Results: After adjusting for potential confounders, children born by C/S appeared significantly more likely than
those born vaginally to report ever wheezing (OR 1.36, 95% CI 1.07-1.71), asthma diagnosis (OR 1.41, 95% CI
1.09-1.83) and be atopic (OR 1.67, 95% CI 1.08-2.60). There was modest evidence that family history of allergies may
modify the effect of C/S delivery on atopy (p for effect modification=0.06) but this was not the case for the
asthma outcomes. Specifically, while more than a two-fold increase in the odds of being a topic was observed in
children with a family history of allergies if born by C/S (OR 2.62, 95% CI 1.38-5.00), no association was observed in
children without a family history of allergies (OR 1.16, 95% CI 0.64-2.11).
Conclusions: Birth by C/S is associated with asthma and atopic sensitization in childhood. The association of C/S
and atopy appears more pronounced in children with family history of allergies.
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In recent decades, there has been an increase in the pro-
portion of children born by caesarean section (C/S) be-
yond the recommended by WHO level of 15%. Rises
were mostly observed in developed nations such as the
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distribution, and reproduction in any mediumother European countries [3]. In England, for example,
in year 2010, 23.4% of singletons were delivered by C/S
[4]. In Cyprus, the Perinatal Health Survey performed in
year 2007 by the Statistical Services of the country esti-
mated the C/S rate to be as high as 50.9% [5]. During
this period, a rise in the prevalence of asthma and aller-
gies was also observed and, to date, a number of studies
have examined a possible link between allergic diseases
and mode of delivery [6-13]. The potential effect of C/S
on asthma and allergies is thought to be mediated
through immunological mechanisms, mainly focusing onntral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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ure to vaginal microbial flora. Differences in the expos-
ure to maternal vaginal or intestinal flora have been
shown to be associated with alteration in the neonatal
gut microflora [14,15] and neonatal cytokine response
patterns [16] which can subsequently lead to changes in
the Th1/Th2 helper cells balance and the risk of devel-
oping atopy [17-19]. However, epidemiological studies
investigating whether the risk of developing allergic con-
ditions is associated with mode of delivery have not al-
ways produced consistent findings [6,8].
Two meta-analyses, both published in 2008, summar-
ized the existing evidence. Reviewing a total of 20 arti-
cles, the study by Thanagnanam et al. reported a
statistically significant 20% increase in the risk of devel-
oping asthma in children born by C/S [20]. The second
meta-analysis by Bager et al. [21] summarized across a
total of 26 studies the association of C/S with 6 different
allergic outcomes including food and inhalant atopy. It
concluded that only 1-4% of the increase in the allergic
outcomes studied can be attributed to C/S delivery
whilst no association was observed between C/S delivery
and inhalant atopy and atopic dermatitis. Interestingly,
both groups of authors noted the lack of studies that
examined the association in non-atopic and atopic asth-
matics separately. It is possible that this association may
be different in the atopic and non-atopic asthma pheno-
types since research evidence suggests that risk factors
associated with asthma might be different for each
asthma phenotype. Indeed, the results of a more recent
longitudinal study [22], showed that C/S delivery was
positively associated with allergic rhinitis and atopy, but
not asthma, among 432 children aged 9 years with a par-
ental history of atopic diseases,. Interestingly, another
prospective study from the Netherlands followed 2917
children from birth to 8 years of age and showed that
the association of C/S delivery with asthma was stronger
in children of two atopic parents than in children of
non-allergic parents whilst in contrast to the previous
study, no association was shown with atopy [23]. There-
fore the evidence on whether the association between C/S
delivery and allergic diseases is dependent on atopic
background is so far limited and contrasting. In this
study, we aimed to investigate the association between
asthma outcomes and atopic sensitization with mode of
delivery amongst 7–8 year old children and assess
whether any effect of C/S delivery is differential in chil-
dren with and without a family history of allergies.
Methods
Study population and design
In year 2008, we invited all children attending the sec-
ond grade of public primary schools (i.e. 7–8 years of
age, n=4583) in the two most populous districts of theRepublic of Cyprus (i.e. Nicosia and Limassol) to partici-
pate in a cross sectional study which primarily aimed to
reassess asthma and allergy prevalence in Cyprus. Par-
ents of participating children were asked to complete
the study questionnaire which consisted of the Greek
version of the ISAAC core questionnaire and a series of
questions on demographic and lifestyle characteristics.
The following year, we invited a randomly selected sam-
ple amongst the participating children of the original
survey who resided in the district of Nicosia to attend
Makarios Children’s Hospital (the tertiary paediatric hos-
pital in Cyprus) in order to undergo amongst other
assessments skin prick testing (SPT) to 11 aeroallergens
(as described below). The study was approved by the
Cyprus National Bioethics Committee. Written consent
was obtained from the parents or legal guardians of all
study participants.
Definition of mode of delivery
A question on the child’s mode of delivery was included
in the study questionnaire by which the parents provided
information on whether the child was born either by va-
ginal delivery or by C/S. For the purposes of the statis-
tical analysis, mode of delivery was considered a binary
variable as no distinction could be made from the avail-
able information between emergency or elective C/S.
Definition of asthma outcomes
Based on answers given to the relevant questions in the
ISAAC core questionnaire, we studied the following self-
reported asthma outcomes: (a) Ever Wheeze (Has your
child ever had wheezing or whistling in the chest at any
point in time?), (b) Current Wheeze (Has your child had
wheezing or whistling in the chest in the past 12
months?), (c) Ever Asthma (Has your child ever had
asthma?) as well as (d) the composite measure Active
Asthma, which was defined as a positive response to
having Ever Asthma together with a positive response
regarding Current Wheeze.
Definition of atopic sensitization
We performed SPT on the volar aspect of the lower arm
of the children whose parents consented to the specific
test. Children who had (a) personal history of an ana-
phylactic reaction in the past and/or (b) wheezing on
auscultation on the day of the examination and/or (c) an
acute asthma attack in the preceding four weeks and/or
(d) a personal history of severe cardiac conditions were
excluded from SPT for safety reasons.
For SPT we used extracts for eleven aero-allergens
(Greer Allergy immunotherapy) that are considered
common in Cyprus: house dust mite (Dermatophagoides
farinae and Dermatophagoides pteronyssinus), olive
(olea europaea), mugwort (artemisia vulgaris), weed mix
Kolokotroni et al. BMC Pediatrics 2012, 12:179 Page 3 of 9
http://www.biomedcentral.com/1471-2431/12/179(kochia scoparia/ chenopodium album/ salsola kali),
grass mix (poa pratensis/ dactylis glomerata/ phleum
pretense), bahia grass (paspalum notatum), mold mix
(alternaria tenuis/ aspergilus niger/ helminthosporidium
sativum/ hormodendrum hordei/ penicillum chryso-
genum), cat hair (felis catus), dog epithelia (canis famil-
iaris), mouse epithelia (mus musculus) and cockroach
mix (periplaneta americana/ blatella germanica). The
procedure was standardized using histamine as a positive
and glycerinated saline as a negative control. We consid-
ered a SPT result as positive if the wheal diameter was
3mm or larger after we subtracted the diameter of the
negative control wheal. A child was considered as having
atopic sensitization if he or she had a positive SPT to at
least one of the above allergens.
Definition of other variables
In order to control for the potential confounding effect
of socio-demographic and/or other risk factors on the
association between mode of delivery and asthma/atopy
outcomes, the following a priori selected variables were
considered in multivariable analyses: sex, country of
birth (Cyprus or elsewhere), district of residence (i.e.
Nicosia or Limassol), urban/rural environment, sibling
order (first-, second, third or higher born), parental level
of education (defined as the highest level of educational
attainment by at least one of the parents: primary, sec-
ondary or tertiary education), exclusive breastfeeding for
at least 2 months, nursery attendance in the first year of
life, sharing bedroom with older siblings any time from
birth up to age 5, current exposure to parental smoking
at home, history of maternal smoking during pregnancy,
low birth weight (less than 2500 gram) and family his-
tory of allergy (i.e. whether father and/or mother and/or
sibling reportedly had a history of asthma and/or eczema
and/or hayfever).
Statistical analysis
We calculated prevalence estimates (overall as well as
stratified by mode of delivery) for each of the asthma
outcomes by dividing the number of positive responses
to the given question in the ISAAC questionnaire by the
total number of participants expressed as percentages;
missing or inconsistent values were taken to be a nega-
tive response. Prevalence estimates of atopic sensitization
were calculated by dividing the number of children iden-
tified as having a positive SPT to at least one allergen
by the total number of children that underwent the test.
The 95% confidence intervals around all the prevalence
estimates were constructed using the normal large-
sample approximation for the standard error of a single
proportion. The representativeness of the sub-group of
participants (i.e. children who responded to the call to
participate in the second round of hospital assessmentsincluding the SPT) in terms of their socio-demographic
characteristics was assessed in chi-squared tests against
the total sample.
Odds ratios (OR’s) of asthma and atopy outcomes
under study by mode of delivery were estimated in mul-
tivariable logistic models adjusting for the effect of po-
tential confounders known a priori to be associated with
outcomes and exposures. As information regarding the
gestational age at birth was not available, the birth
weight of the participants was included in the models. In
addition, all analyses were repeated after excluding chil-
dren with a birth weight of less than 2.5 Kg. Finally, we
assessed for any evidence of modification in the magni-
tude of effect in children with and without family history
of allergy by including an interaction term between fam-
ily history of allergy and mode of delivery. Evidence for
effect modification was assessed in Likelihood Ratio
Tests comparing the goodness of fit of models with and
without the interaction term. All statistical analyses were
performed using the SPSS 18 software package. Statis-
tical significance was set at p < 0.05.
Results
The characteristics of the participating children are pre-
sented in Table 1. Out of the 4583children invited, we
obtained completed questionnaires from 2216 children
aged 7–8 years (representing 48% of all children in this
age range attending public primary schools in the dis-
tricts of Nicosia and Limassol). Reasons for low partici-
pation include the increasing reluctance of parents to
offer personal information and the rise in the number of
surveys among the school population in Cyprus. There
were about equal numbers of boys and girls while the
vast majority of participants were born in Cyprus. As
many as 31.7% of the participants were born by C/S, a
percentage lower than the one reported by the only Peri-
natal Health Survey performed on the island in the year
2007, which might reflect a worrying increase in the per-
centage of children born by CS in Cyprus in less than a
decade. More than 1 in 3 children (37%), as reported by
their parents, had a positive family history of allergies
while 39% were currently exposed to tobacco smoke at
home.
A total number of 797 children from Nicosia took part in
hospital assessments including performance of SPT. This
corresponds to 71% of the children that resided in Nicosia
and took part in the ISAAC survey. We assessed allergic
sensitization in 746 of the 797 children. Fifty one children
were excluded from undergoing this test either due to par-
ental refusal to consent for the specific test and/or because
they met one or more of the exclusion criteria.
No significant differences in terms of most of
the socio-demographic and risk characteristics were
observed between the subgroup of children that











Sex Male 50.5 50.3
Country of Birth Cyprus 95.3 95.4
Sibling Order 1st 38.7 39.4
2nd 34.3 33.7









None or Primary 1.4 1.0
Secondary 44.9 40.2
Tertiary 53.7 58.8**















first year of life
Yes 9.2 9.6
Bedroom sharing Yes 37.4 38.5
*, ** P-value <0.05 and <0.01 respectively in chi-squared test comparing the
sub-group who underwent SPT with all participants.
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the children who only participated in the questionnaire
part of the study. Nevertheless, a significantly higher
proportion of children who participated in hospital
assessments were breastfed for more than two months
(46.1% vs 40.9%, p<0.01), reported a positive family his-
tory of allergies (41.8% vs 37%, p<0.05) and had at least
one parent who attained tertiary education level (58.8%
vs 53.7%, p<0.05).
In Table 2, we present the prevalence estimates of
asthma/atopy outcomes by mode of delivery as well as
the association between mode of delivery and the out-
comes under study expressed as OR’s as estimated in
univariable and multivariable logistic models. In the un-
adjusted models, the odds of all asthma outcomes ap-
pear significantly increased in children born by C/S
compared to those born vaginally. After adjusting for allpotential confounders in multivariable models, the
observed estimates attenuate slightly in all cases but
associations remain statistically significant for two out of
the four outcomes investigated here i.e. ever wheeze
(OR: 1.36, 95% CI: 1.07-1.71) and ever asthma (OR: 1.41,
95% CI: 1.09-1.83). In the subgroup of children that
underwent SPT, the prevalence of atopic sensitization
was higher in children born by C/S compared to those
born vaginally (18.5% vs 13.7%, p-value<0.05). After
adjusting for potential confounders, there was evidence
of significantly higher odds of atopic sensitization at the
age 8–9 years in those born by C/S (OR: 1.67, 95% CI:
1.08-2.60). When the analyses were repeated after the
exclusion of children with a birth weight lower than 2.5
Kg (results not shown in detail), inferences remained un-
affected or attenuated slightly whilst the confidence
intervals around the effect estimates became as expected
slightly wider due to the reduced sample size. For in-
stance, the odds ratio of ever asthma in children born by
C/S compared to vaginally in this group was 1.39, (95%
CI: 1.05-1.85) whilst for ever wheeze and atopic
sensitization were 1.40 (95% CI: 1.08-1.80) and 1.59
(95% CI: 0.99-2.57) respectively.
Table 3 presents the effect estimates of the association
of mode of delivery with asthma and atopic sensitization
stratified by family history of atopy. Effect estimates for
asthma outcomes were generally of similar magnitude in
those with and without family history of atopy both be-
fore and after adjustments. In contrast, there was mod-
est evidence of effect modification by family history of
atopy in the case of atopic sensitization (p value for
Likelihood Ratio Test for effect modification=0.06). Even
though statistical significance was slightly short of sig-
nificance at the 5% level, pronounced differences in the
magnitude of effect between the two groups were
observed. In children with a family history of atopy, the
odds of atopic sensitization was increased by at least
two-fold in those born by C/S compared to those born
vaginally (OR 2.62, CI: 1.38-5.00). In contrast, this does
not seem to be the case in children with no family his-
tory of atopy where no association with mode of delivery
was observed (OR 1.16, CI: 0.64-2.11).
Discussion
Main findings
We investigated whether delivery by C/S is associated
with asthma and atopy outcomes at age 7–9 years and
assessed whether this relationship differs in children
with and without a family history of allergic diseases.
After adjusting for potential confounders, positive asso-
ciations of C/S delivery with ever wheeze, ever asthma
diagnosis and atopic sensitization were observed. While
no effect modification by family history of atopy was
observed in terms of the asthma outcomes, there was
Table 2 Association between mode of delivery and asthma and allergy outcomes at age 8–9 years
Outcomes Total Population Prevalence (95% CI) Odds ratios by mode of delivery (Born by C/S Vs vaginally)
Born vaginally Born by C/S Unadjusted OR (95% CI),
p-value
Adjusted OR† (95% CI),
p-value
Whole sample* n=2216 n= 1500 n= 695
Ever Wheeze 25.0 23.1 29.5 1.38 (1.13-1.69), 1.36 (1.07- 1.71)
(23.2-26.8) (21.0-25.2) (26.1-32.9)
Current Wheeze 8.6 7.5 11.1 1.53 (1.13-2.08) 1.23 (0.87- 1.74)
(7.4-9.8) (6.2-8.8) (8.8-13.4)
Ever Asthma 17.6 15.9 21.3 1.44 (1.14-1.80) 1.41 (1.09- 1.83)
(16.0-19.2) (14.0-17.8) (18.3-24.3)
Active Asthma 5.7 5.1 7.2 1.44 (1.00-2.08) 1.23 (0.81- 1.88)
(4.7-6.7) (4.0-6.2) (5.3-9.1)
Sub-group* n=746 n= 507 n= 354
Atopic Sensitization 15.1 13.7 18.5 1.47 (0.98- 2.20) 1.67 (1.08- 2.60)
(12.6-17.6) (10.8-16.6) (13.7-23.3)
† Adjusted for sex, country of birth, district, urban/rural residence, birth order, parental level of education, parental smoking at home, mother smoking during
pregnancy, exclusive breastfeeding for more than 2 months, birth weight <2500 gr., nursery attendance in the first year of life, bedroom sharing with older
sibling, and family history of allergy. * Numbers reflect missing values on some variables.
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sensitization was particularly pronounced in the pres-
ence of family history of allergies. In fact, among those
without family history of allergies, atopic sensitization
was not found to be associated with C/S.
Limitations
Despite the cross sectional design of the study, the tem-
poral sequence of the exposure and outcomes in this
study is clear. In addition the self – reporting nature of
the mode of delivery is unlikely to have lead to misclassi-
fication of the exposure as parents usually report accur-
ately the mode of delivery of their child. Of course,
information bias in terms of self reporting asthma out-
comes as well as other covariates (e.g. family history of
allergies or birth weight) cannot be excluded. Neverthe-
less, there is no reason to believe that any such bias
should occurred differentially with regards to the mode
of delivery. Even though the participation rate in the
questionnaire survey was rather low, the final sample
corresponds to about half of all children in this age
range. While it is not unlikely that asthmatic children
may have been more inclined to participate in the study
and may have been overrepresented in the sample (and
as a result inflate the prevalence estimates), there is no
reason to believe that the participation rate could have
affected the study outcomes differentially in terms of
mode of delivery (i.e. there is no reason why more asth-
matics born by C/S or more non-asthmatics born vagi-
nally would have participated in the study). Another
limitation of our study is the lack of available informa-
tion on some potential confounding factors such as
transient tachypnea of the newborn [24], pregnancycomplications (e.g. prematurity and intrauterine growth
retardation -IUGR) and delivery complications. How-
ever, in view of the fact that many of these variables as
well as birth weight are strongly correlated [25], it is
not uncommon for studies to avoid adjusting for all, es-
pecially if adding them to the model does not seem to
affect the findings [23]. In this study, we used low birth
weight as a surrogate parameter primarily for both pre-
maturity and IUGR and all analyses were repeated after
exclusion of children with a low birth weight. Never-
theless, we adjusted in our model for other important
confounding factors such as maternal smoking during
pregnancy and exclusive breastfeeding for longer than
two months and parental educational level [26]. Finally
it should be noted that we only investigated atopic
sensitization using inhalant allergens and have not
included food allergens in our assessment although
summary of evidence so far has shown the association
of C/S delivery with atopic sensitization to be stronger
in the case of food allergens than inhalant allergens
[21] and hence this association would have probably
been stronger should we have included food allergens
in our panel of antigens in SPT’s.
Association between delivery by C/S and asthma
A number of epidemiological studies have investigated
the risk of having asthma in individuals born by C/S.
Two recent meta-analyses have reported a modest in-
crease in the risk of asthma in children born by C/S
[20,26]. In this study, we have also shown associations
between delivery by C/S and all asthma outcomes inves-
tigated. Specifically, in the case of ever wheeze and ever
asthma, the effect estimates did not attenuate after
Table 3 Prevalence and odds ratios (and 95% CI) of asthma and atopic sensitization at age 8–9 by mode of delivery, stratified by family history of allergy




























All children* N=929 N=413 N=531 N=259
Ever Wheeze 15.2(12.9-17.5) 19.9 (16.0-23.8) 1.38 (1.02-1.87) 1.45 (1.05-2.00) 37.3 (33.2-41.4) 44.8 (38.7-50.9) 1.36 (1.00-1.83) 1.27 (0.92-1.75) 0.55
Current Wheeze 4.1 (2.8-5.4) 6.8 (4.4-9.2) 1.70 (1.03-2.82) 1.54 (0.89-2.64) 13.7 (10.8-16.6) 17.8 (13.1-22.5) 1.37 (0.92-2.06) 1.07 (0.69-1.66) 0.31
Ever Asthma 10.5 (8.5-12.5) 13.3 (10.0-16.6) 1.30 (0.91-1.84) 1.40 (0.96-2.05) 25.6 (21.9-29.3) 34.4 (28.6-40.2) 1.54 (1.11-2.12) 1.42 (1.00-2.01) 0.96
Active Asthma 2.7 (1.7-3.7) 3.4 (1.7-5.1) 1.26 (0.65-2.46) 1.19 (0.57-2.46) 9.6 (7.1-12.1) 13.5 (9.3-17.7) 1.49 (0.94-2.36) 1.25 (0.76-2.07) 0.90
Sub-group* N=289 N=137 N=204 N=89
Atopic sensitization 14.8 (10.8-18.8) 15.0 (9.2-20.8) 1.04 (0.60-1.81) 1.16 (0.64-2.11) 12.1 (7.8-16.4) 24.2 (15.8-32.6) 2.42 (1.30-4.96) 2.62 (1.38-5.00) 0.06
† Adjusted for sex, country of birth, district of residence, urban/rural residence, birth order, parental level of education, parental smoking at home, mother smoking during pregnancy, birth weight < 2500 gr., exclusive
breastfeeding for more than 2 months, nursery attendance in the first year of life, bedroom sharing with older sibling. ‡ P-value for effect modification by family history of allergy in multivariable models. * Numbers
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remained statistically significant.
Due to unavailability of data, it was not possible to in-
vestigate the association of CS with asthma outcomes
differentially in children born by elective and emergency
CS. Likewise, it would have been preferable to adjust the
observed association for prematurity; nevertheless in our
study inferences remain unaffected both when adjusting
for birth weight (as a surrogate for prematurity) as well
as when the analyses are restricted to those with a birth
weight higher than 2.5 Kg. Furthermore, prematurity in
the literature has been associated with increased risk of
asthmatic symptoms but not with the development of al-
lergies [27] and thus is unlikely to confound the
observed association of C/S with atopic sensitization.
In both meta analyses, the authors commented on the
inconsistency of findings in the literature and suggested
that to some extent the observed heterogeneity may be
attributed to differences in methodology, study designs
and the populations under study (adults vs children), use
of different asthma outcome definitions, the effect of
bias and lack of appropriate adjustment for confounders,
limited statistical power due to small sample size etc. It
is also likely that the association of delivery by C/S and
asthma differs in atopic and non atopic children and,
therefore, by not distinguishing on the basis of atopic
background effect estimates may be reflecting a mixed
picture.
Indeed, the study by Roduit et al. [23] found that the
association of C/S and asthma was more pronounced in
children with one or two allergic parents, although no
test for effect modification was provided. In contrast,
our analysis did not reveal any difference in the esti-
mates of the effect of C/S delivery on any of the asthma
outcomes in children with and without family history of
allergies indicating probably that the positive association
of CS delivery with asthma outcomes found in our study
is important in both children with and without family
history of allergies. On the contrary, the findings of the
longitudinal study by Pistiner et al. did not find any evi-
dence of a positive association of C/S delivery and
asthma disease or symptom in 432 nine year old chil-
dren with parental history of atopy. Therefore, the effect
of genetic predisposition on the association of asthma
with C/S delivery remains unclear and further research
is needed to address this potential interaction.
Association between delivery by C/S and atopic
sensitization
Nine studies to date, all prospective in nature, have inves-
tigated the potential association of atopic sensitization
with C/S delivery using objective methods i.e. food
challenge [28], IgE specific levels [9,23,29] and SPT
[1,3,15,16,30] to food and/or inhalant allergens. Whilesome of these studies have a small sample size [6] or
have tested for only a small number of allergens [31],
the majority could not replicate an association between
delivery by C/S and atopic sensitization [6,8,9,23,31,32].
A recent review [33] as well as one of the meta-analyses
[21] could not verify this association and concluded that,
if anything, delivery by C/S might be associated with
food but not with inhalant atopy.
Four of these studies examined the potentially modify-
ing effect of family history of atopy or, alternatively,
restricted their investigations to children born to atopic
parents [8,21,23,28] with mixed findings. Maitra et al.
found that the relationship between C/S delivery and
atopy was not differentially affected by maternal history
of hayfever amongst 5,916 seven year-old children in
England [8]. However, a degree of misclassification can-
not be excluded since only maternal history of hayfever
was considered and neither asthma nor eczema were
included in the definition used. Roduit et al. showed no
significant association of C/S with atopy [23]. Even
though, as mentioned earlier, the authors reported that
the association between C/S and asthma was more pro-
nounced amongst children of allergic parents, they
found the opposite to be true for atopy with a more pro-
nounced effect in children of non-allergic parents.
Nevertheless, it is not known to what extent the particu-
larly low rates of C/S in this population together with
the differential non-participation rate observed in this
study (with higher loss to follow up amongst the sub-
jects of the atopic background group) may have possibly
affected the direction of estimates.
In contrast, Pistiner et al. showed that C/S was asso-
ciated with a two-fold increase in the odds of atopy (OR
2.1, CI 1.1-3.9, p=0.02) in children with parental history
of atopy [22]. In addition, the study by Eggesbo et al.
showed that the risk of having a positive food challenge
to an egg was 7 times higher in those born by C/S to al-
lergic mothers compared to those born vaginally to non
allergic mothers amongst 2803 two year-old Norwegian
children [23]. In agreement with these findings in this
study, we also found evidence of an overall association
between C/S delivery and atopy. In addition, we showed
a modest evidence to suggest that this association might
not be independent of family history of allergies as chil-
dren with a family history of atopy have 2.6 times the
odds of having atopic sensitization at age 8–9 years if
born by C/S while no similar association was observed
in children with no family history of allergies.
The differential effect of atopic background has also
been studied in relation to other early life environmental
exposures and asthma development [34]. Indeed, mater-
nal overweight has been shown to be associated with an
increased risk of asthma in children predisposed to
asthma at the age of 8 years whilst no association was
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http://www.biomedcentral.com/1471-2431/12/179observed in children without predisposition. The differ-
ential effect of atopic background might be suggestive of
gene-environment interaction that can influence the de-
velopment of the immune system. It has been previously
shown that atopic and non-atopic children develop dif-
ferent T-helper lymphocyte responses during the first
year of life [35]. More recently, a study investigating the
interaction of day care exposure in the first year of life
with 72 genetic polymorphisms at 45 candidate loci
demonstrated 22 significant interactions of 16 poly-
morphisms with day care attendance on cytokine pro-
files and atopic phenotypes [36]. Furthermore, there is
growing evidence that gene-environment interactions
are also involved in the development of childhood food
allergy [37]. Therefore, the interaction of genetic predis-
position with early life environmental exposures, such as
in the case of delivery by C/S, might play an important
role in the development of allergic and probably other
immune related conditions; this will need to be explored
further in future studies.
Conclusion
Birth by C/S is associated with asthma and atopic
sensitization in Cypriot children aged 8–9 years. The as-
sociation of C/S delivery with atopic sensitization seems
to be more pronounced in children with family history
of allergy but this is not the case for asthma. Further
studies are needed to investigate the potential inter-
action of genetic predisposition with C/S delivery and
their effect on immune responses and asthma/atopy de-
velopment in childhood.
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